Recent Studies from Hospital Clinic of Barcelona Add New Data to Solid Cancer (Determinants of Activity and Efficacy of Anti-pd1/pd-l1 Therapy In Patients With Advanced Solid Tumors Recruited In a Clinical Trials Unit: a Longitudinal ...).

Předmět:	CLINICAL trials MEDICAL societies HOSPITALS IMMUNE checkpoint inhibitors MEDICAL research
Zdroj:	Immunotherapy Weekly; 2/23/2023, p546-546, 1p
Abstrakt:	Keywords: Barcelona; Spain; Europe; Biomarkers; Cancer; Clinical Research; Clinical Trials and Studies; Diagnostics and Screening; Drugs and Therapies; Genetics; Health and Medicine; Immunology; Immunotherapy; Oncology; Solid Cancer EN Barcelona Spain Europe Biomarkers Cancer Clinical Research Clinical Trials and Studies Diagnostics and Screening Drugs and Therapies Genetics Health and Medicine Immunology Immunotherapy Oncology Solid Cancer 2023 FEB 21 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on Oncology - Solid Cancer. To resume, in our prospective observational pan-cancer study, baseline LIPI score, immunotherapy-naive status, cancer type and RT before starting ICI were the most relevant clinical factors independently correlated with immunotherapy outcomes.". [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu